BIO Welcomes Advances In Stem Cell ResearchBIO President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique: "The creation of stem cells lines carrying the genes or genetic components of ten diseases is a great step forward in the quest to understand, treat and eventually cure disease.StemCells, Inc. To Present On Batten Disease To The California Institute Of Regenerative Medicine's Oversight CommitteeStemCells, Inc. (NASDAQ:STEM) announced that it has accepted an invitation by the California Institute of Regenerative Medicine (CIRM) to present on Batten Disease at the upcoming meeting of CIRM's Independent Citizens Oversight Committee (ICOC). At the meeting, Ann Tsukamoto, Ph.D., the Company's Chief Operating Officer, and Stephen Huhn, M.D., F.A.C.S., F.A.A.P.Putting MicroRNAs On The Stem Cell MapEmbryonic stem cells are always facing a choice-either to self-renew or begin morphing into another type of cell altogether. It's a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key regulators known as "master transcription factors," proteins that switch gene expression on or off.Scientists Replicate Diseases In The Lab With New Stem Cell LinesA set of new stem cell lines will make it possible for researchers to explore ten different genetic disorders-including muscular dystrophy, juvenile diabetes, and Parkinson's disease-in a variety of cell and tissue types as they develop in laboratory cultures. Researchers led by Howard Hughes Medical Institute investigator George Q. Daley have converted cells from individuals with the diseases into stem cells with the same genetic errors.Daley And Colleagues Create 20 Disease-Specific Stem Cell Lines - Lines To Be Part Of New HSCI IPS Collection Available To ResearchersHarvard Stem Cell Institute researcher George Q. Daley, MD, PhD, also associate director of the Stem Cell Program at Children's Hospital Boston, and HSCI colleagues Konrad Hochedlinger and Chad Cowan have produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The paper is being published in the August 6 on-line edition of the journal Cell.Daley And Colleagues Create 20 Disease-Specific Stem Cell Lines - Lines To Be Part Of New HSCI IPS Collection Available To ResearchersHarvard Stem Cell Institute researcher George Q. Daley, MD, PhD, also associate director of the Stem Cell Program at Children's Hospital Boston, and HSCI colleagues Konrad Hochedlinger and Chad Cowan have produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The paper is being published in the August 6 on-line edition of the journal Cell.
Definition Of Consumer Driven Health Care
Quantitative Methods In Healthcare Management
Janet Jackson Weight Loss Diet
Breast Cancer In The Lungs
Health Education Posters
Stop Acid Reflux Gerd
Antihistamines And Impotence
Fargo Health Savings Account
Independent Health Medisource
Medical Transcription Courses
Pituitary Gland Tumors Simptoms
Alicia Keys Aids Awareness Commercial
Current Health News Articles
Nursing Patterns Maternity Clothes Breastfeeding
Family Tree
No comments:
Post a Comment